Meningococcal Carriage

Meningococcal carriage refers to the presence of Neisseria meningitidis bacteria in the back of the throat without causing illness. Most carriers never develop disease, but they can transmit the bacterium to close contacts who may be more vulnerable. Carriage rates vary by age and setting, with young adults in shared living environments, including university halls and military barracks across South and Southeast Asia, showing higher colonisation rates.

Medicine used to treat Meningococcal Carriage

Rifampin Tablets

Rifampicin

150 · 300 · 450 · 600mg

Intended to mitigate bacterial load, to target tuberculosis infection.

From $0.39 / tablet View

Clearing the bacterium

Carriage itself rarely causes symptoms, so treatment is only recommended in specific situations, such as before or after a case of invasive meningococcal disease in a household or close contact. The goal is to eliminate the organism from the throat and prevent onward transmission.

Rifampicin is one of the established agents used for meningococcal carriage clearance, belonging to the broader class of antibiotics active against this pathogen. Short treatment courses are standard; full adherence matters because incomplete courses can allow the bacterium to persist.

If you or someone in your household has been identified as a close contact of a confirmed meningococcal case, seek medical assessment promptly.